Genesis Clinical Research Fall River, MA - 02720

Genesis Clinical Research is categorized under Business Consultants in Fall River, MA and active since 2009.

Genesis Clinical Research was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 5419100 by the NAICS.

If you are seeking more information, feel free to contact Elizabeth Donaghey, Manager at the company’s single location by writing to 373 New Boston Road # 2, Fall River, Massachusetts MA 02720 or by phoning (508) 672-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genesis Clinical Research
Contact Person: Elizabeth Donaghey, Manager
Address: 373 New Boston Road # 2, Fall River, Massachusetts 02720
Phone Number: (508) 672-5100
Website Address: crcgenesis.com
Annual Revenue (USD): Unknown
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Consultants
SIC Code: 8748
NAICS Code: 5419100
Share This Business:

Genesis Clinical Research was started in 2009 to provide professional Business Consultants under the SIC code 8748 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Elizabeth Donaghey, Manager for inquiries that concern Genesis Clinical Research by calling the company number (508) 672-5100, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesis Clinical Research can be found at the coordinates 41.70997,-71.13897 as well as the street address 373 New Boston Road # 2 in Fall River, Massachusetts 02720.

For its online presence, you may visit Genesis Clinical Research’s website at crcgenesis.com and engage with its social media outlets through on Twitter and on Facebook.